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†Department of Biology and ‡Department of Physics and Astronomy, University of Waterloo, Waterloo, Ontario, CanadaABSTRACT Amyloid fibrils are associated with multiple neurodegenerative disorders, such as Alzheimer’s disease. Although
biological membranes are involved in fibril plaque formation, the role of lipid membrane composition in fibril formation and toxicity
is not well understood. We investigated the effect of cholesterol on the interaction of model lipid membranes with amyloid-
b peptide (Ab). With atomic force microscopy we demonstrated that binding of Ab (1–42) to DOPC bilayer, enriched with
20% cholesterol, resulted in an intriguing formation of small nonuniform islands loaded with Ab. We attribute this effect to the
presence of nanoscale electrostatic domains induced by cholesterol in DOPC bilayers. Using frequency-modulated Kelvin probe
force microscopy we were able to resolve these nanoscale electrostatic domains in DOPC monolayers. These findings directly
affect our understanding of how the presence of cholesterol may induce targeted binding of amyloid deposits to biomembranes.
We postulate that this nonhomogeneous electrostatic effect of cholesterol has a fundamental nature andmay be present in other
lipid membranes and monolayers.Received for publication 7 March 2012 and in final form 21 June 2012.
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http://dx.doi.org/10.1016/j.bpj.2012.06.053Although amyloid fibril plaque accumulations have
been observed on the surface neuronal cells in vivo in test
subjects with Alzheimer’s disease (1,2) the role of cell
membrane composition and the presence of cholesterol on
fibril plaque formation and toxicity are still not well under-
stood. Studies have shown that amyloid interacts with the
membrane and that it is vital in amyloid fibril formation
and toxicity (3,4). Although cholesterol is an important
constituent of lipid rafts and is thought to regulate various
important functions of the membrane (5), the role of choles-
terol in the molecular mechanism of amyloid toxicity is not
clear. Cholesterol has been shown to influence the fluidity
of total brain extract, cell death, and the extent to which
Ab fibrillogenesis occurs (6). The effect of this sterol on
the membrane is very complex and is still debated to
this day (7,8).
We recently discovered an interesting electrostatic effect
of cholesterol on pulmonary surfactant BLES and showed
that cholesterol inhibits surfactant function (9). These
intriguing electrostatic properties of cholesterol may be
important for understanding the interaction of the plasma
membrane with amyloid-forming peptides. Lipid bilayers
and monolayers are widely used to mimic biological mem-
branes (7) to study their structure and interaction with
biomolecules (6,10,11).
In this work we used atomic force microscopy (AFM) and
frequency-modulated Kelvin probe force microscopy (FM-
KPFM) (see the Supporting Material) to investigate the
effect of cholesterol on the structure of dioleoyl-sn-glycero-
3-phosphocholine (DOPC) bilayers and monolayers and to
study how this affects Ab (1–42) binding and fibril forma-
tion. DOPC bilayers with and without cholesterol wereprepared as described in the Supporting Material;
deposited on mica; incubated with Ab (1–42) solution in
buffer; and then rinsed with water and imaged in water.
As shown in Fig. 1 a, Ab deposits on the pure DOPC bila-
yers were small, spherical, and uniformly distributed across
the lipid membrane surface with no preferential binding
sites or clustering. Amyloid fibril formation on DOPC mem-
branes with 20% cholesterol showed quite different and
striking results (Fig. 1 b)—amyloid deposits were binding
to the lipid membrane in a nonuniform, selective manner,
which resulted in the formation of nanoscale islands or
domains (from tens to hundreds nm in size) enriched with
amyloid deposits (Fig. 1, and see the Supporting Material).
The amyloid deposits observed on the DOPC/cholesterol
membrane were clusters of spherical oligomers and short
fibrils. To estimate the disruptive effect of Ab deposits on
the lipid membranes, we evaluated the roughness parame-
ters of the membrane surfaces for both samples. The surface
of the pure DOPC membrane with Ab deposits was rela-
tively smooth with Ab deposits slightly sinking into the
membrane (Fig. 1, a and c); this correlates with our previous
data (11). The domains of clustered Ab deposits on the
DOPC/cholesterol bilayer showed rough surfaces corre-
sponding to the domains saturated with Ab deposits and
smooth areas of pure membrane (Fig. 1, b and d). The core
roughness Sk (12), (see Fig. S1 in the Supporting Material)
is slightly lower for pure DOPC membrane (0.75 0.1 nm)
FIGURE 1 AFM topography images of Ab binding to the lipid membrane. (a) Pure DOPC membrane after 1 h incubation with Ab
(1–42). (b) DOPC membrane with 20% cholesterol after 1 h incubation with Ab (1–42). (c) Surface roughness (see the Supporting
Material) of the pure DOPC membrane with Ab deposits corresponding to the rectangular area marked in panel a. (d) Surface rough-
ness of the cholesterol-enriched DOPC membrane with Ab deposits corresponding to the rectangular area marked in panel b.
L28 Biophysical Lettersthan for cholesterol-enriched DOPC membrane (0.8 5
0.1 nm). The reduced valley depth Svk is significantly higher
for the cholesterol-enriched DOPC membrane (0.5 5
0.1 nm) than for the pure DOPC membrane (0.24 5
0.03 nm), which corresponds to increased damage (deeper
holes produced) in the membrane by Ab deposits.
It was reported that cholesterol induces a small thickening
of the DOPC membrane (13), which may result in the
formation of topographical domains that we observe; this
indicates the coexistence of liquid-ordered and liquid-disor-
dered phases (5). In addition, using FM-KPFM (14,15), we
show that these domains are also electrostatic in nature
(Fig. 2). Fig. 2 shows AFM topography (Fig. 2, a and b)
and corresponding FM-KPFM surface potential images
(Fig. 2, c and d) of pure DOPC monolayer (Fig. 2, a and c)
and monolayer with 20% cholesterol (Fig. 2, b and d). The
pure DOPC lipid monolayer is smooth and (Fig. 2 a) has
uniform featureless surface potential (Fig. 2 c), whereas
the DOPC lipid monolayer with 20% of cholesterol shows
domains in topography (Fig. 2 b) and in surface potential
(Fig. 2 d). These domains have a surface potential difference
of 615 8 mVmeasured from potential image cross sections
(see the Supporting Material).
Considering the charged nature of Ab (16), we expect that
electrostatic domains created in the DOPC lipid membranesBiophysical Journal 103(4) L27–L29by cholesterol attract the Ab peptide, thus inducing nonho-
mogeneous islands or domains that are densely packed with
amyloid deposits (shown on Fig. 1 b). Earlier, we discovered
that cholesterol-induced nanoscale electrostatic domains are
crucial for the function of pulmonary surfactant and its
interaction with charged nanoparticles (9). We postulate
that this previously unknown electrostatic effect of choles-
terol is not specific to pulmonary surfactant films and ex-
tends to other self-assembled amphiphilic structures such
as lipid monolayers and lipid membranes, and, therefore,
can alter the interaction of charged or polar biomolecules
with the surface of lipid membrane. In this work, we demon-
strated that this electrostatic effect of cholesterol may serve
as a driving force for amyloid binding to lipid membranes
and thus supports the hypothesis that cholesterol is involved
in the mechanism of amyloid toxicity.SUPPORTING MATERIAL
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